What Voltarol does

Voltarol is a UK consumer healthcare brand wholly owned by Haleon plc (LSE: HLN), the consumer health company demerged from GlaxoSmithKline in 2022. The brand manufactures and markets over-the-counter topical pain relief products built around diclofenac as the active pharmaceutical ingredient, including 1.16% and 2.32% Emulgel formulations, once-daily medicated plasters delivering up to 12 hours of relief, and drug-free heat patches providing up to 8 hours of thermal therapy. The portfolio is anchored by proprietary Emulgel technology, which combines gel and cream properties with a permeation enhancer to drive diclofenac through the skin, supported by a diclofenac skin-reservoir mechanism that provides sustained release into underlying tissues.

The brand targets UK adults with joint, muscle, back, and osteoarthritis pain who prefer topical alternatives to oral NSAIDs, with secondary messaging aimed at athletes and runners through the TCS London Marathon Official Pain Relief Partnership. Voltarol operates a horizontal go-to-market: products are stocked behind pharmacy counters and in major UK retailers, supplemented by online pharmacy and e-commerce partners. The GTM motion is direct-to-consumer via content marketing (a comprehensive health-education platform covering pain types, exercise, mental wellbeing, and complementary therapies), YouTube video content, and event sponsorship.

Commercially, Voltarol generates revenue through one-time OTC purchases of physical SKUs at pharmacy, retail, and online channels. The brand operates as a sub-brand within Haleon's broader Pain Relief category — which Haleon reports as a sub-segment of its $11B+ group revenue — and does not disclose brand-level financials. Voltarol is currently UK-only under its name (the global Voltaren franchise belongs to Haleon), and the brand continues to extend the portfolio into adjacent segments such as natural/plant-based pain relief via the Voltanatura sub-brand.

Name

Voltarol

Legal name

Voltarol (brand owned by Haleon)

Website

https://voltarol.co.uk

Company type

Private

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Voltarol is a UK consumer healthcare brand owned by Haleon plc that manufactures and sells over-the-counter topical diclofenac-based pain relief products — including Emulgel formulations, medicated plasters, and heat patches — targeting adults with joint, muscle, back, and osteoarthritis pain.

Ownership category

akta.pro rank

Product category

Topical Pain Relief (OTC Consumer Healthcare)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

akta.pro secondary industry

Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)

Keywords

• Topical pain relief
• OTC diclofenac gels
• Medicated plasters
• Joint pain treatment
• Consumer healthcare

Headquarters

HQ city

Brentford

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

1. OTC Topical Pain Relief Products: Voltarol generates revenue through the sale of over-the-counter topical pain relief products including medicated gels, medicated plasters, and heat patches. Products are sold as one-time purchases through pharmacies and retail stores. The brand targets consumers seeking topical alternatives to oral pain medications for joint pain, muscle pain, back pain, and osteoarthritis symptoms.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Voltarol manufactures and sells over-the-counter topical pain relief products, including diclofenac-based medicated gels, medicated plasters, and drug-free heat patches, for consumers in the UK managing joint, muscle, back, neck, and osteoarthritis pain. Products are distributed through pharmacies, retail stores, and online pharmacy partners, leveraging proprietary Emulgel technology for enhanced skin penetration and sustained relief. The brand also offers a plant-based sub-brand, Voltanatura, for natural soothing.

Product overview

Voltarol is a pain relief brand offering topical gels, medicated plasters, and heat patches. The core product line includes three main gel formulations: Voltarol Max Strength Pain Relief 2.32% Gel (highest diclofenac concentration for intensive joint/back pain), Voltarol Back & Muscle Pain Relief 1.16% Gel (standard concentration for general pain relief), and Voltarol Osteoarthritis Joint Pain Relief 1.16% Gel (specifically for osteoarthritis). All gels use proprietary Emulgel technology for enhanced skin penetration. The portfolio also includes Voltarol Medicated Plasters (diclofenac sodium patches providing up to 12-hour relief) and Voltarol Drug Free Heat Patches (non-medicated thermal therapy providing up to 8 hours of heat). A newer addition is Voltanatura, an organic plant-based sub-brand. All products contain diclofenac as the active NSAID ingredient except the heat patches which are drug-free.

Differentiator

Problem solved

Functional benefit

Brands

• Voltanatura: Organic plant-based cooling and soothing gel - a natural sub-brand within the Voltarol product range

Products and services

• Voltarol Max Strength Pain Relief 2.32% Gel A high-concentration diclofenac topical gel (2.32% diclofenac) using Emulgel technology with a permeation enhancer to penetrate deep into joints and tissue, providing up to 12 hours of sustained pain relief for consumers with joint, back, and muscle pain. Available in 100g with an easy-open flip-top cap for users with joint pain.
• Voltarol Back & Muscle Pain Relief 1.16% Gel A standard-concentration diclofenac topical gel (1.16% diclofenac) using Triple Effect formulation that relieves pain, reduces inflammation, and helps speed natural healing. Targeted at back and muscle pain for consumers seeking OTC topical relief.
• Voltarol Osteoarthritis Joint Pain Relief 1.16% Gel A 1.16% diclofenac topical gel formulated specifically for osteoarthritis, penetrating deep into joints to relieve pain, reduce inflammation, and help speed natural healing. Designed for osteoarthritis sufferers needing ongoing joint pain management.
• Voltarol Medicated Plasters Topical once-a-day medicated plasters containing diclofenac sodium that provide continuous, sustained pain relief for up to 12 hours for muscle pain, with easy application for consumers seeking mess-free alternatives to gels.
• Voltarol Drug Free Heat Patch Drug-free heat patches providing up to 8 hours of targeted heat to relax tight muscles and help relieve pain. Suitable for consumers seeking non-medicated thermal therapy for muscle pain.
• Voltanatura Organic Plant-Based Cooling and Soothing Gel An organic, plant-based cooling and soothing gel sub-brand within the Voltarol range, offering natural pain relief for consumers preferring non-pharmaceutical soothing options.

Quantifiable outcome

• 3x more effective pain relief vs. placebo (in acute neck pain)
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• TCS London MarathonflagshipGTM or Marketing PartnerVoltarol is the Official Pain Relief Partner of the TCS London Marathon. This partnership includes brand sponsorship, content marketing (running tips, injury management, scenic routes), and product support for runners. The partnership aligns with Voltarol's target audience of active individuals who experience sports injuries and muscle pain.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Voltaren (Global brand under Haleon): Voltaren is the global sister brand of Voltarol, using the same Emulgel diclofenac platform sold outside the UK. It serves as the most direct comparable, with international scale that Voltarol lacks.
• Deep Relief: Deep Relief (by Mentholatum) is a direct UK competitor offering topical ibuprofen-based pain relief gels targeting similar muscle and joint pain use cases through pharmacy retail channels.
• Tiger Balm: Tiger Balm is an established topical analgesic brand offering menthol/camphor-based pain relief rubs and patches, competing for the same muscle and joint pain consumer occasions as Voltarol.
• Movelat: Movelat is a direct competitor offering topical anti-inflammatory creams and gels for joint and muscle pain in the UK OTC market, with comparable pharmacy distribution and consumer positioning.
• Salonpas: Salonpas (Hisamitsu) is a global OTC topical pain patch brand, offering medicated and non-medicated patches for localized pain relief that compete directly with Voltarol's Medicated Plaster and Heat Patch formats.
• Biofreeze: Biofreeze is a leading menthol-based topical pain relief brand (Performance Health), directly competing in the sports-recovery and chronic-pain segments that Voltarol targets with its heat patches and gels.
• Ibuleve: Ibuleve is a direct competitor providing topical ibuprofen gel for musculoskeletal pain relief, sold OTC in UK pharmacies and competing head-to-head with Voltarol for the same consumer occasions.

Broad incumbents

• Icy Hot (Chattem/Sanofi): Icy Hot is Sanofi Consumer Health's broad topical pain relief portfolio, including patches, creams, and sprays, offering overlapping capabilities to Voltarol's gels and patches as part of a wider brand portfolio.
• Panadol (Haleon): Panadol is a sister brand under Haleon, competing across the broader UK OTC pain category with oral paracetamol-based products and capturing demand that could otherwise flow to Voltarol for systemic pain.
• Nurofen (Reckitt): Nurofen is Reckitt's flagship pain relief brand in the UK, with topical gels alongside oral NSAIDs, competing for the same OTC pain consumer wallet share as Voltarol.

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCoF-DK1xcRbci6XBljJ5RXQ
• LinkedInlinkedin.com/company/voltarol-gb

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Voltarol